Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Nippon India Mutual Fund

Nippon India Pharma Fund Direct-Growth

NAV
returns change indicator
335.0027
as on 21 Sep 2021, 11:15 PM
2.6569(0.80%)
Last Change
loaderloader

Start SIP in this Mutual Fund

Min SIP Amount
100
Suggested Date
22nd of Every Month

Investment Performance

would have given a return of
1,10,871
star
1,21,647
star
1,89,290
star
1,94,332
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
94,332
Profit (absolute return)
94.33%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
5.60%
In the last 6 months
28.82%
In the last 1 year
33.26%
In the last 3 years
94.33%
In the last 5 years
120.46%
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
low to moderate
low to moderate
moderate
moderate
moderately high
moderately high
high
high
very high
very high
indicator
Investors understand that their principal will be at very high risk

Scheme Information

Nippon India Pharma Fund Direct-Growth
Nippon India Pharma Fund Direct-Growth
as of 31 Aug 2021, 05:30 AM
5,667.10 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 month.
1.14%
Expense Ratio
Plan
Growth
4.55%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 month.
Scheme Document

Sectors Holding in this Mutual Fund

as on 31 Aug 2021
Sort By
Healthcare
95.29%
5,400.17 Cr
Cash Holding
4.55%
257.85 Cr

Companies Holding in this Mutual Fund

as on 31 Aug 2021
Sort By
Sun Pharmaceutical Industries Ltd.
10.40%
589.38 Cr
Divi's Laboratories Ltd.
9.54%
540.64 Cr
Dr. Reddy's Laboratories Ltd.
7.99%
452.80 Cr
Cipla Ltd.
7.81%
442.60 Cr
Aurobindo Pharma Ltd.
7.78%
440.90 Cr
Lupin Ltd.
6.65%
376.86 Cr
Fortis Healthcare Ltd.
5.14%
291.29 Cr
Others
4.77%
270.32 Cr
Thyrocare Technologies Ltd.
4.36%
247.09 Cr
Apollo Hospitals Enterprise Ltd.
4.28%
242.55 Cr
View All
View All

About Nippon India Pharma Fund Direct-Growth

Nippon India Pharma Fund Direct-Growth is a Equity mutual fund scheme from Nippon India Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹5,667.10 Crores and the latest NAV decalared is ₹335.003 as on 22 Sep 2021 at 2:21 am.
Nippon India Pharma Fund Direct-Growth scheme return performance in last 1 year is 33.26%, in last 3 years is 94.33% and 379.50% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.

Scheme Details

AUM:5,667.10 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End

Scheme Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

AMC Information

Nippon India Mutual Fund
Nippon India Mutual Fund
View AMC Details
2,70,354.77 Cr
AUM
211
Schemes
Address
Address
Reliance Centre, 7th Floor, South WingOff Western Express HighwaySantacruz (East)400055
Phone Number
Phone Number
Phone : 022-68334800 / 18602660111
Fax : 022-33037662